Analysts Set AptarGroup, Inc. (NYSE:ATR) Price Target at $181.60

Shares of AptarGroup, Inc. (NYSE:ATR - Get Free Report) have received a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $181.60.

ATR has been the subject of several research reports. Bank of America downgraded shares of AptarGroup from a "buy" rating to a "neutral" rating and set a $173.00 price objective for the company. in a research report on Monday, January 6th. Robert W. Baird lowered their price objective on shares of AptarGroup from $185.00 to $160.00 and set an "outperform" rating for the company in a research report on Monday, February 10th. StockNews.com lowered shares of AptarGroup from a "buy" rating to a "hold" rating in a research report on Monday, February 10th. Raymond James reiterated an "outperform" rating and set a $190.00 target price (down from $200.00) on shares of AptarGroup in a research report on Monday, February 10th. Finally, Wells Fargo & Company decreased their price target on AptarGroup from $180.00 to $170.00 and set an "overweight" rating for the company in a research note on Monday, February 10th.

Remove Ads

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Norges Bank bought a new stake in AptarGroup during the fourth quarter worth $116,265,000. FMR LLC grew its holdings in AptarGroup by 33.1% during the 4th quarter. FMR LLC now owns 2,481,563 shares of the industrial products company's stock valued at $389,854,000 after buying an additional 617,365 shares in the last quarter. Bank of America Corp DE lifted its stake in AptarGroup by 297.2% in the 4th quarter. Bank of America Corp DE now owns 473,021 shares of the industrial products company's stock worth $74,312,000 after purchasing an additional 353,935 shares in the last quarter. Jupiter Asset Management Ltd. bought a new stake in AptarGroup during the fourth quarter valued at $22,925,000. Finally, Raymond James Financial Inc. bought a new position in AptarGroup in the 4th quarter worth about $21,941,000. Hedge funds and other institutional investors own 88.52% of the company's stock.

AptarGroup Stock Down 0.7 %

Shares of NYSE:ATR traded down $0.98 during trading on Friday, hitting $147.01. 325,226 shares of the company's stock traded hands, compared to its average volume of 291,634. AptarGroup has a 52 week low of $135.96 and a 52 week high of $178.03. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. The company has a 50-day moving average price of $150.31 and a 200-day moving average price of $158.82. The company has a market cap of $9.78 billion, a price-to-earnings ratio of 26.54, a price-to-earnings-growth ratio of 3.89 and a beta of 0.56.

AptarGroup (NYSE:ATR - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The industrial products company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.24. AptarGroup had a net margin of 10.45% and a return on equity of 15.56%. As a group, research analysts forecast that AptarGroup will post 5.57 EPS for the current fiscal year.

AptarGroup Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 5th were issued a $0.45 dividend. The ex-dividend date was Wednesday, February 5th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.22%. AptarGroup's dividend payout ratio is presently 32.49%.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.